MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and
MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and warehousing. The company also plans to expand its cobalt-60 production facility by 5000 sq ft. The project will be complete by August 1999, according to the Canadian radiopharmaceutical firm. In addition to cobalt-60, MDS Nordion processes and distributes molybdenum that it receives from Atomic Energy of Canada (AECL).
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.